Survey of the effect of Gingko Biloba on cataract

Determination of the effect of Gingko Biloba? extract on redox state of human serum and aqueous albumin in patients with senile cataract

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190912044755N1

Enrollment

146

Registered

2019-10-10

Start date

2015-02-19

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Senile cataract. Age-related cataract

Interventions

Intervention 1: Intervention group: GBE,capsule 200 mg po,daily for 16weeks. Intervention 2: Control group: placebo,capsule 200 mg po,daily for 16weeks.

Eligibility

Sex/Gender

All

Age

50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Senile cataract

Exclusion criteria

Exclusion criteria: History of cardiac diseases History of renal diseases History of neurological diseases History of Diabetes Mellitus History of rheumatologic diseases History of hematologic diseases History of thyroid diseases Receiving of estrogen-steroid, immunosuppressive and anticoagulant-anti platelet agents History of ophthalmic diseases and surgery

Design outcomes

Primary

Measure	Time frame
Posterior Capsule Opacification. Timepoint: 6, 12, 36 weeks after cataract surgery. Method of measurement: Slit-lamp bio microscopic examination of eyes.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Ahmadzadeh Amiri

Sari University of Medical Sciences

ahmadzdh@yahoo.com+98 11 3332 5734

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026